Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Wuxi Biologics
Research and Development in Biotechnology (except Nanobiotechnology)ChinaPNK: WXXWY
Last verified 7 months agowuxibiologics.com
Wuxi Biologics, a leading global player in the biotechnology sector, is headquartered in Wuxi, China. Founded in 2010, the company has rapidly established itself as a key provider of research and development services in biotechnology, excluding nanobiotechnology. With a strong presence in major operational regions across Asia, Europe, and North America, Wuxi Biologics focuses on offering comprehensive solutions for biologics development, including cell line development, process development, and analytical services.
The company is renowned for its innovative approach and state-of-the-art facilities, which enable it to deliver high-quality biologics at an accelerated pace. Wuxi Biologics has achieved significant milestones, including numerous partnerships with leading pharmaceutical companies, solidifying its position as a trusted partner in the biopharmaceutical industry. With a commitment to excellence and a robust portfolio of services, Wuxi Biologics continues to drive advancements in biotechnology.
57
DitchCarbon score
+30 vs industry average
Wuxi Biologics’s score of 57 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Wuxi Biologics?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Research and Development in Biotechnology (except Nanobiotechnology) is among the most carbon-intensive industries
Industry performance
0.198
20182025
The Research and Development in Biotechnology (except Nanobiotechnology) industry has reduced its overall emissions by 19% since 2018
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Wuxi Biologics's reported carbon emissions
In 2025, WuXi Biologics, headquartered in China and operating in Biotechnology Research and Development, reported total Scope 1 emissions of 44,125,000 kg CO2e and Scope 2 emissions of 185,605,000 kg CO2e. Their Scope 3 emissions for 2025 included approximately 3,895,000 kg CO2e from business travel, 22,532,000 kg CO2e from employee commute, 5,948,000 kg CO2e from waste generated in operations, 47,052,000 kg CO2e from fuel and energy related activities, 3,565,000 kg CO2e from upstream transportation and distribution, and 1,746,000 kg CO2e from downstream transportation and distribution.
In 2024, the company's Scope 1 emissions were 38,346,000 kg CO2e, and Scope 2 emissions were 160,308,000 kg CO2e. Key Scope 3 emissions included approximately 2,470,000 kg CO2e from business travel, 19,176,000 kg CO2e from employee commute, 5,868,000 kg CO2e from waste generated in operations, 39,468,000 kg CO2e from fuel and energy related activities, 2,175,000 kg CO2e from upstream transportation and distribution, and 2,087,000 kg CO2e from downstream transportation and distribution.
For 2023, WuXi Biologics recorded Scope 1 emissions of 32,687,000 kg CO2e and Scope 2 emissions of 149,229,000 kg CO2e. Their Scope 3 emissions included about 2,101,230 kg CO2e from business travel, 19,654,270 kg CO2e from employee commute, 5,040,100 kg CO2e from waste generated in operations, 35,385,140 kg CO2e from fuel and energy related activities, 2,251,280 kg CO2e from upstream transportation and distribution, and 1,031,750 kg CO2e from downstream transportation and distribution.
The company has set several climate commitments. WuXi Biologics (Cayman) Inc. aims to achieve net-zero greenhouse gas emissions across its value chain by 2050. Near-term targets include reducing absolute Scope 1 and 2 GHG emissions by 58.8% by 2034 from a 2024 base year. They also plan to reduce Scope 3 GHG emissions, specifically from purchased goods and services, by 63.8% per kg of product produced within the same timeframe. Long-term targets commit to a 90% reduction in absolute Scope 1 and 2 GHG emissions by 2050 from a 2024 base year, and a 90% reduction in absolute Scope 3 GHG emissions (covering purchased goods and services, capital goods, fuel and energy related activities, upstream transportation and distribution, waste generated in operations, and employee commuting) by 2050 from a 2024 base year. These targets are consistent with reductions required to limit global warming to 1.5°C.
Additionally, WuXi Biologics has a mid-term goal to reduce its Scope 1 and Scope 2 GHG emission intensity by 50% (tonnes/RMB10,000) by 2030, using a 2020 base year.
Assessing Wuxi Biologics as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Wuxi Biologics and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Wuxi Biologics’s Climate Goals (2030 & 2050)
7 goals2050
90% reduction in Scope 2
WuXi Biologics (Cayman) Inc. commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2050 from a 2024 base year.
Behind target90%
2050
90% reduction in scope 3 total
WuXi Biologics (Cayman) Inc. commits to reduce absolute scope 3 GHG emissions covering purchased goods and services, capital goods, fuel and…
Behind target90%
2050
90% reduction in Scope 1
WuXi Biologics (Cayman) Inc. commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2050 from a 2024 base year.
Behind target90%
See all 7 climate goals
Sign up to see all goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
6 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
2034 targetSee details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Wuxi Biologics7 months ago
57
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Wuxi Biologics’s sustainability data and climate commitments
In 2025, Wuxi Biologics reported total Scope 1 and 2 emissions of approximately 229.7 million kg CO2e. Scope 2 emissions accounted for the largest share, around 185.6 million kg CO2e, while Scope 1 emissions were approximately 44.1 million kg CO2e. The company also disclosed Scope 3 emissions across various categories, indicating a comprehensive approach to tracking its environmental impact within the biotechnology research and development sector.
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more